High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

MLA

Chabannon, C., et al. “High-Dose Chemotherapy Followed by Reinfusion of Selected CD34+ Peripheral Blood Cells in Patients with Poor-Prognosis Breast Cancer: A Randomized Multicentre Study.” British Journal of Cancer, vol. 78, no. 7, Oct. 1998, pp. 913–21. EBSCOhost, https://doi.org/10.1038/bjc.1998.601.

APA

Chabannon, C., Cornetta, K., Lotz, J.-P., Rosenfeld, C., Shlomchik, M., Yanovitch, S., Marolleau, J.-P., Sledge, G., Novakovitch, G., Srour, E., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, D., Maraninchi, D., Mills, B., & Kunkel, L. (1998). High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study. British Journal of Cancer, 78(7), 913–921. https://doi.org/10.1038/bjc.1998.601

Chicago

Chabannon, C, K Cornetta, J-P Lotz, C Rosenfeld, M Shlomchik, S Yanovitch, J-P Marolleau, et al. 1998. “High-Dose Chemotherapy Followed by Reinfusion of Selected CD34+ Peripheral Blood Cells in Patients with Poor-Prognosis Breast Cancer: A Randomized Multicentre Study.” British Journal of Cancer 78 (7): 913–21. doi:10.1038/bjc.1998.601.